Exanta Superiority To Warfarin Could Reduce Safety Concerns – Cmte.

AstraZeneca's Exanta should demonstrate more definitive superiority to Bristol-Myers Squibb's Coumadin (warfarin) prior to approval, FDA's Cardiovascular & Renal Drugs Advisory Committee agreed